BioSpace News Archive

The global healthcare industry has integrated technological advancements so as to offer high-end services to the patients.

Cardiff Oncology, Inc. announced the pricing of its previously announced underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $13.50 per share.

Multiple trends and drivers are helping the global veterinary insemination market chart growth over the forecast period of 2019 to 2027.

Certain changes in a person’s heart and breathing rates could precede symptoms of COVID-19, an increasing number of studies suggests. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005184/en/ Purdue University researchers are helping to develop physIQ software that could indicate that a person should get tested for COVID-19 by detecting s

The healthcare landscape is undergoing massive changes and a large section of these is positive. One of the most significant and positive impacts noted here is that of technological advancement.

The worldwide pain management devices market includes an inexorably aggressive scene set apart by rising degree of rivalry among its players.

Rising incidence of diabetes that has risk of developing into neuropathic pain is fuelling the neuropathic pain management market.

Development partners establish supply chain agreements and order sufficient drug substance to treat 1 million patients

Game-changing offering leverages the power of machine learning to fill critical information gaps in the early-stage pharmaceutical pipeline

Hemogenyx Pharmaceuticals plc, the Standard Listed biopharmaceutical group developing therapies designed to transform blood disease treatment, announces unaudited interim results for the six-month period ended 30 June 2020.